Powell Lab at Penn
Share
Cancer immunotherapy with a focus on adoptive T cell transfer and cancer vaccination.
07/04/2020
Daniel Powell, PhD, Associate Professor in the Department of Pathology & Laboratory Medicine & the Department of Obstetrics & Gynecology at UPENN and an international expert in translational immunotherapy will be our guest speaker in our Virtual Ovarian Cancer Support Group Meeting this Friday at 2 pm EST. He’ll be giving an update on ovarian cancer research. If you would like to attend, please email Jennie at [email protected]. This pic is from the Sandy Sprint Philly. Dan is a team captain. His shirt is very fitting since he’s one of our superheroes!
25/03/2020
Our newest paper from the lab, from recent graduate Dr. Nicholas Minutolo.
Quantitative Control of Gene-Engineered T cell Activity Through Covalent Attachment of Targeting Ligands to a Universal Immune Receptor Universal immune receptors represent a rapidly emerging form of adoptive T cell therapy with the potential to overcome safety and antigen escape challenges faced by conventional chimeric antigen receptor (CAR) T cell therapy. By decoupling antigen recognition and T cell signaling domains via bifunct...
12/12/2019
The latest paper to come out from the Powell Lab!
An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer The aim of this study was to “humanize” ovarian cancer patient-derived xenograft (PDX) models by autologous transfer of patient-matched tumor infiltra…
07/10/2019
Powell lab bonding at the Carl June Solid Tumors Beware Party 🎃👻🕷️🕸️🎉
Check out the latest OCRC newsletter, just in time for Ovarian Cancer Awareness Month. Lab members Anze Smole and Lauren Shaw are featured!
17/12/2018
Happy Holidays from the Powell Lab!
Check out the latest OCRC Newsletter! Two of our lab members, Sarah Gitto and Alba Rodriguez-Garcia, are featured!
25/04/2018
Some photos from this past weekend at the Sandy Sprint with Sandy Rollman Ovarian Cancer Foundation, Inc.
25/04/2018
17/04/2018
A great article from CNN about a personalized immunotherapy trial that was developed at Penn!
Ovarian cancer vaccine shows promising results in human study A personalized cancer vaccine lengthened the lives of patients with ovarian cancer, a small clinical trial demonstrated.
26/03/2018
It's that time of year again! Join the Penn OCRC team for the Sandy Sprint. Lace up your sneakers and put on your superhero best!
Sandy Sprint Superhero 5K or 10K Run/Walk & Canine Sprint Presented by JadeYoga Supporting the Sandy Rollman Ovarian Cancer Foundation's Fight to End Ovarian Cancer